Skip to content

Clinical trials

Phase 1/2 Liver Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 1/2 Country / region: Taiwan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20141
20161
20191
20224
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arbutus Biopharma Corporation1
Bristol-Myers Squibb1
DualityBio Inc.1
Eisai Inc.1
Eureka Therapeutics Inc.1
Light Sciences Oncology1
Novartis Pharmaceuticals1
Omega Therapeutics1
Pfizer1
PhytoCeutica1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms10
Carcinoma, Hepatocellular8
Endometrial Neoplasms2
Neoplasms2
Bile Duct Neoplasms1
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Cholangiocarcinoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.